|Bid||16.96 x 1300|
|Ask||17.84 x 1800|
|Day's Range||15.99 - 17.29|
|52 Week Range||11.25 - 59.50|
|Beta (5Y Monthly)||1.19|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 03, 2022 - Aug 08, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||26.23|
Subscribe to Yahoo Finance Plus to view Fair Value for HCAT
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has documented over 5.4 million lives positively impacted by improvement initiatives, $1.5 billion in validated measurable improvements, and 300 case studies – a result of its data and analytics technology, professional services, and deep customer relationships.
SALT LAKE CITY, June 01, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the following upcoming investor conferences: William Blair’s 42nd Annual Growth Stock Conference, being held in Chicago on Tuesday, June 7, 2022, inclu
As you might know, Health Catalyst, Inc. ( NASDAQ:HCAT ) just kicked off its latest quarterly results with some very...